Alpha Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.71M Buy
15,764
+168
+1% +$57.5K 0.74% 40
2026
Q1
$5.49M Sell
15,596
-28
-0.2% -$9.98K 0.8% 41
2025
Q4
$5.11M Buy
15,624
+32
+0.2% +$10.2K 0.72% 48
2025
Q3
$4.4M Buy
15,592
+555
+4% +$161K 0.7% 55
2025
Q2
$4.2M Buy
15,037
+504
+3% +$143K 0.72% 53
2025
Q1
$4.53M Buy
14,533
+376
+3% +$111K 0.86% 43
2024
Q4
$3.69M Buy
14,157
+623
+5% +$185K 0.68% 54
2024
Q3
$4.36M Buy
13,534
+129
+1% +$42.2K 0.82% 43
2024
Q2
$4.19M Buy
13,405
+298
+2% +$87.5K 0.82% 45
2024
Q1
$3.73M Buy
+13,107
New +$3.84M 0.73% 53

Other funds holding AMGN

Alpha Capital Management's AMGN Position: Q2 2026 in Review

Alpha Capital Management increased its Amgen (AMGN) stake by 1.1% in Q2 2026, buying an estimated $57.5K and bringing the position to 15,764 shares worth $5.71M. The position accounts for 0.74% of the portfolio, ranked #40.

Alpha Capital Management first reported a position in AMGN in Q1 2024 and has held it in 10 quarters since. 3,156 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Alpha Capital Management held 15,764 shares of Amgen worth $5.71M as of Q2 2026.
  • Alpha Capital Management bought 168 Amgen shares in Q2 2026, an estimated $57.5K.
  • Amgen made up 0.74% of Alpha Capital Management's portfolio in Q2 2026, its #40 holding.
  • Alpha Capital Management first reported a position in Amgen in Q1 2024 and has held it in 10 quarters since.
  • 3,156 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Alpha Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.